GSK announced partial success in its late-stage ovarian cancer trials, where their drug Jemperli showed improved outcomes ...
GSK's latest ovarian cancer trial achieved its primary goal by improving patient survival through a combination of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback